ENTRY       D09680                      Drug
NAME        Teprotumumab (USAN/INN);
            Teprotumumab (genetical recombination) (JAN);
            Teprotumumab-trbw;
            Tepezza (TN)
PRODUCT     TEPEZZA (Horizon Therapeutics USA)
FORMULA     C6476H10012N1748O2000S40
EXACT_MASS  145548.4297
MOL_WEIGHT  145637.9001
SEQUENCE    (Heavy chain)
            QVELVESGGG VVQPGRSQRL SCAASGFTFS SYGMHWVRQA PGKGLEWVAI IWFDGSSTYY
            ADSVRGRFTI SRDNSKNTLY LQMNSLRAED TAVYFCAREL GRRYFDLWGR GTLVSVSSAS
            TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGK
            (Light chain)
            EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD ASKRATGIPA
            RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSKWPPWTFG QGTKVESKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H145-H201, H62-H322, H368-H426, H227-H'230, L23-L88, L135-L195, H221-L215)
  TYPE      Peptide
REMARK      ATC code: L04AA53
            Product: D09680<US>
EFFICACY    Anti-inflammatory, Insulin-like growth factor 1 receptor antibody
  DISEASE   Thyroid eye disease [DS:H02402]
  TYPE      Monoclonal antibody
COMMENT     Treatment of Graves' disease
TARGET      IGF1R (CD221) [HSA:3480] [KO:K05087]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L04 IMMUNOSUPPRESSANTS
               L04A IMMUNOSUPPRESSANTS
                L04AA Selective immunosuppressants
                 L04AA53 Teprotumumab
                  D09680  Teprotumumab (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Ophthalmic Agents, Other
               Ophthalmic Agents, Monoclonal Antibodies
                Teprotumumab
                 D09680  Teprotumumab (USAN/INN)
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                IGF1R (CD221)
                 D09680  Teprotumumab (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09680
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09680
DBLINKS     CAS: 89957-37-9
            PubChem: 124490420
///
